Cuba has announced the setting up of BioCubaFarma, the Biotechnological and Pharmaceutical Industry Group, from the merger of scientific centers, with the aim of producing medicines, equipment and services for the population and for exports, reports ACN, the Cuban news agency.
The initiative comes after a decision by the Cuban Council of State, through decree 307, dated November 27, 2012. The new conglomerate of 38 companies also includes entities within the Quimefa group and it was conceived following the technical and scientific level achieved by the country.
The decision to set up BioCubaFarma is in tune with the economic and social guidelines approved by the 6th Congress of the Cuban Communist Party about the consolidation of the pharmaceutical and biotechnological industry as one of the country’s areas with higher export capacity, and able to introduce new products into the local market to replace imports.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze